The novel treatment of this peptide represents a major advance in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide642202.mybjjblog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-54201451